Industry expert (USA)

Geoff McDonough


Geoffrey McDonough, M.D. is CEO of Generation Bio and also helps lead the work of biotechnology companies Surface Oncology and Zafgen. Geoff last worked in the field of haemophilia when he served as President and CEO of Swedish Orphan Biovitrum AB (Sobi), a Swedish pharmaceutical company for six years (2011-2016). 

Prior to joining Sobi, Geoff held several senior leadership positions at Genzyme Corporation (2002-2011), including Senior Vice President and General Manager, Personalized Genetic Health, Senior Vice President, Lysosomal Storage Disease (LSD) Therapeutics and President of Europe, Middle East and Africa (EMEA).

Prior to this, Geoff co-founded and served as President of Catalyst Medical Solutions, a developer of software for hospital management, and was a practising internist and paediatrician. He holds a BA and BSc. from the University of North Carolina at Chapel Hill, and an MD from Harvard Medical School.